Rocket Doctor Joins Heal.LA Accelerator to Boost Virtual Care Access

Treatment.com International ( (TSE:TRUE) ) has shared an announcement.

Rocket Doctor, a digital health platform under Treatment.com AI, has been selected to join the 2025 Heal.LA Accelerator Cohort by the Larta Institute. This selection is intended to enhance Rocket Doctor’s mission of providing tech-enabled virtual care to underserved communities, particularly in Los Angeles and Southern California. The program offers mentorship, regulatory guidance, and funding access, which will help Rocket Doctor expand its service reach and establish new partnerships. This move is expected to increase patient bookings and visibility among new patient populations, addressing chronic disease and healthcare access challenges in high-need areas.

Spark’s Take on TSE:TRUE Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRUE is a Underperform.

Treatment.com International is struggling financially, with persistent losses and negative cash flow overshadowing recent revenue growth. The stock is technically weak, and valuation metrics highlight its unprofitable status. However, recent corporate events, including strategic acquisitions and partnerships, provide some potential for future growth, although they have not yet addressed the core financial challenges.

To see Spark’s full report on TSE:TRUE stock, click here.

More about Treatment.com International

Treatment.com AI Inc. is a company leveraging artificial intelligence and clinical best practices to address inefficiencies in the healthcare sector. It has developed the Global Library of Medicine (GLM), an AI engine providing clinical information and support to healthcare professionals, aiming to reduce administrative burdens and enhance patient care quality.

Average Trading Volume: 118,861

Technical Sentiment Signal: Sell

Current Market Cap: C$23.49M

For a thorough assessment of TRUE stock, go to TipRanks’ Stock Analysis page.